Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Updates in Thyroid Cytology.

Nishino M, Krane JF.

Surg Pathol Clin. 2018 Sep;11(3):467-487. doi: 10.1016/j.path.2018.05.002. Review.

PMID:
30190135
2.

Ancillary testing in salivary gland cytology: A practical guide.

Jo VY, Krane JF.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:627-642. doi: 10.1002/cncy.22010. Review.

PMID:
30156767
3.

Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma.

Schoenfeld JD, Gjini E, Rodig SJ, Tishler RB, Rawal B, Catalano PJ, Uppaluri R, Haddad RI, Hanna GJ, Chau NG, Rabinowits G, Lorch J, Jo VY, Krane JF, Goguen LA, Annino DJ, Abdelrahman S, Lipschitz M, Margalit DN.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):137-145. doi: 10.1016/j.ijrobp.2018.05.002. Epub 2018 Jun 29.

PMID:
29960819
4.

Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.

Mito JK, Bishop JA, Sadow PM, Stelow EB, Faquin WC, Mills SE, Krane JF, French CA, Fletcher CDM, Hornick JL, Sholl LM, Jo VY.

Am J Surg Pathol. 2018 Aug;42(8):1067-1075. doi: 10.1097/PAS.0000000000001064.

PMID:
29683816
5.

Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients ≥70 Years Old.

Wang Z, Vyas CM, Van Benschoten O, Nehs MA, Moore FD Jr, Marqusee E, Krane JF, Kim MI, Heller HT, Gawande AA, Frates MC, Doubilet PM, Doherty GM, Cho NL, Cibas ES, Benson CB, Barletta JA, Zavacki AM, Larsen PR, Alexander EK, Angell TE.

Thyroid. 2018 Apr;28(4):465-471. doi: 10.1089/thy.2017.0655. Epub 2018 Apr 2.

PMID:
29608439
6.

Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule.

Angell TE, Vyas CM, Barletta JA, Cibas ES, Cho NL, Doherty GM, Gawande AA, Howitt BE, Krane JF, Marqusee E, Strickland KC, Alexander EK, Moore FD Jr, Nehs MA.

Ann Surg Oncol. 2018 May;25(5):1410-1417. doi: 10.1245/s10434-018-6421-x. Epub 2018 Mar 8.

PMID:
29520656
7.

Sclerosing mucoepidermoid carcinoma with eosinophilia: Cytologic characterization of a rare distinct entity in the thyroid.

Ames E, Campbell MJ, Afify A, Krane JF, Huang EC.

Diagn Cytopathol. 2018 Jul;46(7):632-635. doi: 10.1002/dc.23914. Epub 2018 Feb 26.

PMID:
29479842
8.

Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP).

Strickland KC, Eszlinger M, Paschke R, Angell TE, Alexander EK, Marqusee E, Nehs MA, Jo VY, Lowe A, Vivero M, Hollowell M, Qian X, Wieczorek T, French CA, Teot LA, Cibas ES, Lindeman NI, Krane JF, Barletta JA.

Endocr Pathol. 2018 Mar;29(1):68-74. doi: 10.1007/s12022-018-9515-x.

PMID:
29396809
9.

Differential Growth Rates of Benign vs. Malignant Thyroid Nodules.

Angell TE, Vyas CM, Medici M, Wang Z, Barletta JA, Benson CB, Cibas ES, Cho NL, Doherty GM, Doubilet PM, Frates MC, Gawande AA, Heller HT, Kim MI, Krane JF, Marqusee E, Moore FD Jr, Nehs MA, Zavacki AM, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4642-4647. doi: 10.1210/jc.2017-01832.

PMID:
29040691
10.

Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.

Strickland KC, Howitt BE, Barletta JA, Cibas ES, Krane JF.

Cancer Cytopathol. 2018 Feb;126(2):86-93. doi: 10.1002/cncy.21922. Epub 2017 Sep 15.

PMID:
28914983
11.

Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.

Sajed DP, Faquin WC, Carey C, Severson EA, H Afrogheh A, A Johnson C, Blacklow SC, Chau NG, Lin DT, Krane JF, Jo VY, Garcia JJ, Sholl LM, Aster JC.

Am J Surg Pathol. 2017 Nov;41(11):1473-1482. doi: 10.1097/PAS.0000000000000945.

12.

A modified reporting approach for thyroid FNA in the NIFTP era: A 1-year institutional experience.

Mito JK, Alexander EK, Angell TE, Barletta JA, Nehs MA, Cibas ES, Krane JF.

Cancer Cytopathol. 2017 Nov;125(11):854-864. doi: 10.1002/cncy.21907. Epub 2017 Sep 13.

13.

Primary Benign and Malignant Thyroid Neoplasms With Signet Ring Cells: Cytologic, Histologic, and Molecular Features.

Farhat NA, Onenerk AM, Krane JF, Dias-Santagata D, Sadow PM, Faquin WC.

Am J Clin Pathol. 2017 Sep 1;148(3):251-258. doi: 10.1093/ajcp/aqx074.

PMID:
28821194
14.

A case of primary secretory carcinoma of the thyroid with high-grade features.

Wu EY, Lebastchi J, Marqusee E, Lorch JH, Krane JF, Barletta JA.

Histopathology. 2017 Oct;71(4):665-669. doi: 10.1111/his.13268. Epub 2017 Jul 13. No abstract available.

15.

HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.

Mito JK, Jo VY, Chiosea SI, Dal Cin P, Krane JF.

Histopathology. 2017 Oct;71(4):511-521. doi: 10.1111/his.13246. Epub 2017 Jul 5.

PMID:
28463429
16.

Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only.

Vivero M, Renshaw AA, Krane JF.

Cancer Cytopathol. 2017 Jul;125(7):534-543. doi: 10.1002/cncy.21858. Epub 2017 Apr 7.

17.

The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas.

Wong KS, Strickland KC, Angell TE, Nehs MA, Alexander EK, Cibas ES, Krane JF, Howitt BE, Barletta JA.

Endocr Pathol. 2017 Jun;28(2):171-176. doi: 10.1007/s12022-017-9476-5.

PMID:
28271380
18.

Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.

Baca SC, Wong KS, Strickland KC, Heller HT, Kim MI, Barletta JA, Cibas ES, Krane JF, Marqusee E, Angell TE.

Cancer Cytopathol. 2017 May;125(5):313-322. doi: 10.1002/cncy.21827. Epub 2017 Feb 2.

19.

Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.

Paulson VA, Shivdasani P, Angell TE, Cibas ES, Krane JF, Lindeman NI, Alexander EK, Barletta JA.

Thyroid. 2017 Apr;27(4):506-511. doi: 10.1089/thy.2016.0583. Epub 2017 Feb 24.

PMID:
28114855
20.

Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma.

Jo VY, Chau NG, Hornick JL, Krane JF, Sholl LM.

Mod Pathol. 2017 May;30(5):650-659. doi: 10.1038/modpathol.2016.239. Epub 2017 Jan 13.

21.

Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer.

Sullivan MC, Graham PH, Alexander EK, Ruan DT, Nehs MA, Gawande AA, Moore FD Jr, Howitt BE, Strickland KC, Krane JF, Barletta JA, Cho NL.

J Am Coll Surg. 2017 Jun;224(6):1021-1027. doi: 10.1016/j.jamcollsurg.2016.12.007. Epub 2016 Dec 23.

PMID:
28017809
22.

The Bethesda System for Reporting Thyroid Cytopathology: Proposed Modifications and Updates for the Second Edition from an International Panel.

Pusztaszeri M, Rossi ED, Auger M, Baloch Z, Bishop J, Bongiovanni M, Chandra A, Cochand-Priollet B, Fadda G, Hirokawa M, Hong S, Kakudo K, Krane JF, Nayar R, Parangi S, Schmitt F, Faquin WC.

Acta Cytol. 2016;60(5):399-405. Epub 2016 Oct 21. Review.

23.

Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma.

Kakarmath S, Heller HT, Alexander CA, Cibas ES, Krane JF, Barletta JA, Lindeman NI, Frates MC, Benson CB, Gawande AA, Cho NL, Nehs M, Moore FD, Marqusee E, Kim MI, Larsen PR, Kwong N, Angell TE, Alexander EK.

J Clin Endocrinol Metab. 2016 Dec;101(12):4938-4944. Epub 2016 Sep 30.

24.

Unusual pleomorphic adenoma of the lacrimal Gland: Immunohistochemical demonstration of PLAG1 and HMGA2 oncoproteins.

Jakobiec FA, Stagner AM, Eagle RC Jr, Lally SE, Krane JF.

Surv Ophthalmol. 2017 Mar - Apr;62(2):219-226. doi: 10.1016/j.survophthal.2016.08.001. Epub 2016 Aug 25. Review.

PMID:
27567603
25.

Coming to terms with NIFTP: A provisional approach for cytologists.

Krane JF, Alexander EK, Cibas ES, Barletta JA.

Cancer Cytopathol. 2016 Nov;124(11):767-772. doi: 10.1002/cncy.21769. Epub 2016 Aug 26. Review. No abstract available.

26.

Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis.

Strickland KC, Vivero M, Jo VY, Lowe AC, Hollowell M, Qian X, Wieczorek TJ, French CA, Teot LA, Sadow PM, Alexander EK, Cibas ES, Barletta JA, Krane JF.

Thyroid. 2016 Oct;26(10):1466-1471. Epub 2016 Sep 8.

PMID:
27457786
27.

Distinctive Patterns of CTNNB1 (β-Catenin) Alterations in Salivary Gland Basal Cell Adenoma and Basal Cell Adenocarcinoma.

Jo VY, Sholl LM, Krane JF.

Am J Surg Pathol. 2016 Aug;40(8):1143-50. doi: 10.1097/PAS.0000000000000669.

PMID:
27259009
28.

Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.

Wong KS, Angell TE, Strickland KC, Alexander EK, Cibas ES, Krane JF, Barletta JA.

Thyroid. 2016 Jul;26(7):911-5. doi: 10.1089/thy.2015.0644.

PMID:
27219469
29.

Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.

Foo WC, Jo VY, Krane JF.

Cancer Cytopathol. 2016 Jun;124(6):397-405. doi: 10.1002/cncy.21693. Epub 2016 Feb 16.

30.

An Avid Imitator.

Farmakiotis D, Liakos A, Miller MB, Krane JF, Baden LR, Hammond SP.

J Clin Med Res. 2016 Mar;8(3):257-9. doi: 10.14740/jocmr2458w. Epub 2016 Jan 26.

31.

Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.

Chau NG, Li YY, Jo VY, Rabinowits G, Lorch JH, Tishler RB, Margalit DN, Schoenfeld JD, Annino DJ, Goguen LA, Thomas T, Becker H, Haddad T, Krane JF, Lindeman NI, Shapiro GI, Haddad RI, Hammerman PS.

Clin Cancer Res. 2016 Jun 15;22(12):2939-49. doi: 10.1158/1078-0432.CCR-15-2314. Epub 2016 Jan 13.

32.

Highlights for the cytology community from the 2015 American Thyroid Association clinical guidelines on the management of thyroid nodules and well-differentiated thyroid cancer.

Alexander EK, Faquin WC, Krane JF.

Cancer Cytopathol. 2016 Jul;124(7):453-6. doi: 10.1002/cncy.21662. Epub 2015 Nov 30. No abstract available.

33.

Fine-needle aspiration diagnoses of noninvasive follicular variant of papillary thyroid carcinoma.

Howitt BE, Chang S, Eszlinger M, Paschke R, Drage MG, Krane JF, Barletta JA.

Am J Clin Pathol. 2015 Dec;144(6):850-7. doi: 10.1309/AJCPEIE12POICULI.

PMID:
26572991
34.

Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis.

Liu X, Medici M, Kwong N, Angell TE, Marqusee E, Kim MI, Larsen PR, Cho NL, Nehs MA, Ruan DT, Gawande A, Moore F Jr, Barletta J, Krane JF, Cibas ES, Yang T, Alexander EK.

Thyroid. 2016 Feb;26(2):256-61. doi: 10.1089/thy.2015.0376. Epub 2015 Dec 16.

35.

The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk.

Kwong N, Medici M, Angell TE, Liu X, Marqusee E, Cibas ES, Krane JF, Barletta JA, Kim MI, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2015 Dec;100(12):4434-40. doi: 10.1210/jc.2015-3100. Epub 2015 Oct 14.

36.

Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma.

Kerr DA, Arora KS, Mahadevan KK, Hornick JL, Krane JF, Rivera MN, Ting DT, Deshpande V, Faquin WC.

Am J Surg Pathol. 2015 Dec;39(12):1643-52. doi: 10.1097/PAS.0000000000000516.

PMID:
26426378
37.

BRAF testing and thyroid FNA.

Pusztaszeri MP, Krane JF, Faquin WC.

Cancer Cytopathol. 2015 Dec;123(12):689-95. doi: 10.1002/cncy.21614. Epub 2015 Sep 3. No abstract available.

38.

The variable phenotype and low-risk nature of RAS-positive thyroid nodules.

Medici M, Kwong N, Angell TE, Marqusee E, Kim MI, Frates MC, Benson CB, Cibas ES, Barletta JA, Krane JF, Ruan DT, Cho NL, Gawande AA, Moore FD Jr, Alexander EK.

BMC Med. 2015 Aug 7;13:184. doi: 10.1186/s12916-015-0419-z.

39.

The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.

Strickland KC, Howitt BE, Marqusee E, Alexander EK, Cibas ES, Krane JF, Barletta JA.

Thyroid. 2015 Sep;25(9):987-92. doi: 10.1089/thy.2014.0612. Epub 2015 Jul 29.

PMID:
26114752
40.

Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.

Brauner E, Holmes BJ, Krane JF, Nishino M, Zurakowski D, Hennessey JV, Faquin WC, Parangi S.

Thyroid. 2015 Jul;25(7):789-96. doi: 10.1089/thy.2015.0049. Epub 2015 Jun 4.

PMID:
25962906
41.

Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.

Krane JF, Cibas ES, Alexander EK, Paschke R, Eszlinger M.

Cancer Cytopathol. 2015 Jun;123(6):356-61. doi: 10.1002/cncy.21546. Epub 2015 Apr 29.

42.

Lessons from early clinical experience with the Afirma gene expression classifier.

Krane JF.

Cancer Cytopathol. 2014 Oct;122(10):715-9. doi: 10.1002/cncy.21472. Epub 2014 Aug 13. No abstract available.

43.

FNAB of benign thyroid nodules with papillary hyperplasia: a cytological and histological evaluation.

Pusztaszeri MP, Krane JF, Cibas ES, Daniels G, Faquin WC.

Cancer Cytopathol. 2014 Sep;122(9):666-77. doi: 10.1002/cncy.21441. Epub 2014 Jun 2.

44.

Human papillomavirus-associated adenocarcinoma of the palatine tonsil--reply.

Hanna JW, Reimann JD, Haddad RI, Krane JF.

Hum Pathol. 2014 Apr;45(4):895. doi: 10.1016/j.humpath.2013.09.022. Epub 2013 Dec 19. No abstract available.

PMID:
24656100
45.

Human papillomavirus-associated adenocarcinoma of the base of tongue: potentially actionable genetic changes.

Chang AM, Nikiforova MN, Johnson JT, Bauman JE, Perez-Ordonez B, Seethala RR, Krane JF, Chiosea SI.

Head Neck Pathol. 2014 Jun;8(2):151-6. doi: 10.1007/s12105-013-0508-2. Epub 2013 Nov 21.

46.

Influence of descriptive terminology on management of atypical thyroid fine-needle aspirates.

Vivero M, Renshaw AA, Krane JF.

Cancer Cytopathol. 2014 Mar;122(3):175-81. doi: 10.1002/cncy.21367. Epub 2013 Nov 7.

47.

Testicular infarction after angioembolization of an ipsilateral renal angiomyolipoma.

Cummings CT, Foreman R, Killoran TP, Krane JF, O'Leary M.

Urology. 2013 Nov;82(5):995-7. doi: 10.1016/j.urology.2013.04.034. Epub 2013 Aug 23. No abstract available.

PMID:
23978372
48.

Immunohistochemical features of lacrimal gland epithelial tumors.

Mendoza PR, Jakobiec FA, Krane JF.

Am J Ophthalmol. 2013 Dec;156(6):1147-1158.e1. doi: 10.1016/j.ajo.2013.06.034. Epub 2013 Aug 20.

PMID:
23972314
49.

Human papillomavirus-associated adenocarcinoma of the base of the tongue.

Hanna J, Reimann JD, Haddad RI, Krane JF.

Hum Pathol. 2013 Aug;44(8):1516-23. doi: 10.1016/j.humpath.2012.12.004. Epub 2013 Mar 1.

PMID:
23465278
50.

Relative sensitivity of thyroid fine-needle aspiration by tumor type and size.

Jo VY, Renshaw AA, Krane JF.

Diagn Cytopathol. 2013 Oct;41(10):871-5. doi: 10.1002/dc.22976. Epub 2013 Feb 28.

PMID:
23447387

Supplemental Content

Loading ...
Support Center